Symbols / SERA $2.14 -1.38% Sera Prognostics, Inc.

Healthcare • Medical Devices • United States • NGM
SERA Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Fundamentals
Scroll to Statements
Market Cap 83.77M Enterprise Value 48.08M Income -31.93M Sales 81.00K Book/sh 1.94 Cash/sh 1.00
Dividend Yield — Payout 0.00% Employees 71 IPO — P/E — Forward P/E -3.12
PEG — P/S 1034.17 P/B 1.11 P/C — EV/EBITDA -1.35 EV/Sales 593.58
Quick Ratio 1.62 Current Ratio 1.69 Debt/Eq 3.10 LT Debt/Eq — EPS (ttm) -0.67 EPS next Y -0.69
EPS Growth — Revenue Growth -58.30% Earnings 2026-05-06 ROA -26.15% ROE -51.83% ROIC —
Gross Margin -102.47% Oper. Margin -895.40% Profit Margin 0.00% Shs Outstand 38.18M Shs Float 27.41M Short Float 1.23%
Short Ratio 3.87 Short Interest — 52W High 4.09 52W Low 1.37 Beta 1.06 Avg Volume 53.68K
Volume 4.45K Target Price $5.00 Recom Strong_buy Prev Close $2.17 Price $2.14 Change -1.38%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$5.00
Mean price target
2. Current target
$2.14
Latest analyst target
3. DCF / Fair value
$-8.23
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.14
Low
$5.00
High
$5.00
Mean
$5.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2023-08-10 main Citigroup Neutral → Neutral $3
2022-11-10 main Citigroup — → Neutral $2
2022-08-29 main Oppenheimer — → Outperform $11
2022-04-27 init Berenberg — → Buy $13
2022-03-30 down Citigroup Buy → Neutral $4
2021-11-19 init Oppenheimer — → Outperform $19
2021-08-09 init William Blair — → Outperform —
2021-08-09 init Citigroup — → Buy $18
2021-08-09 init Cowen & Co. — → Outperform —
News
RSS: Latest SERA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-12 JACKSON BENJAMIN R General Counsel — 44,215 $0.00 $0
2026-03-12 LINDGARDT ZHENYA Chief Executive Officer — 154,440 $0.00 $0
2026-03-12 AERTS AUSTIN Chief Financial Officer — 44,215 $0.00 $0
2026-03-12 ANDERSON DYAARL LEE JR Officer — 12,455 $0.00 $0
2026-03-12 INGLIS TIFFANY EUL DAVIS Officer — 17,437 $0.00 $0
2026-03-11 JACKSON BENJAMIN R General Counsel — 1,027 $2.04 $2,095
2026-03-11 BONIFACE JOHN J Officer — 1,517 $2.04 $3,095
2026-03-11 KEARNEY PAUL Officer — 1,396 $2.04 $2,848
2026-03-11 LINDGARDT ZHENYA Chief Executive Officer — 25,612 $1.90 $49,079
2026-03-11 AERTS AUSTIN Chief Financial Officer — 7,088 $1.90 $13,610
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.08
+5.19%
0.08
-74.84%
0.31
+14.18%
0.27
Operating Revenue
0.08
+5.19%
0.08
-74.84%
0.31
+14.18%
0.27
Cost Of Revenue
0.16
+100.00%
0.08
-60.95%
0.21
+8.81%
0.19
Reconciled Cost Of Revenue
0.16
+100.00%
0.08
-60.95%
0.21
+8.81%
0.19
Gross Profit
-0.08
-1560.00%
-0.01
-105.21%
0.10
+28.00%
0.07
Operating Expense
36.42
-0.57%
36.63
-8.23%
39.92
-12.71%
45.73
Research And Development
13.17
-10.58%
14.73
-3.25%
15.22
+6.89%
14.24
Selling General And Administration
23.25
+6.16%
21.90
-11.31%
24.69
-21.57%
31.48
Selling And Marketing Expense
6.55
+13.46%
5.77
-30.88%
8.35
-43.20%
14.70
General And Administrative Expense
16.70
+3.55%
16.13
-1.31%
16.34
-2.63%
16.78
Other Gand A
16.70
+3.55%
16.13
-1.31%
16.34
-2.63%
16.78
Total Expenses
36.59
-0.35%
36.71
-8.51%
40.13
-12.62%
45.92
Operating Income
-36.50
+0.36%
-36.63
+8.00%
-39.82
+12.77%
-45.65
Total Operating Income As Reported
-36.50
+0.36%
-36.63
+8.00%
-39.82
+12.77%
-45.65
EBITDA
-30.98
+3.30%
-32.04
+9.21%
-35.29
+18.64%
-43.37
Normalized EBITDA
-31.31
+5.28%
-33.05
+11.34%
-37.28
+16.11%
-44.44
Reconciled Depreciation
0.94
+12.85%
0.83
-7.44%
0.90
+19.05%
0.76
EBIT
-31.92
+2.89%
-32.87
+9.17%
-36.19
+17.99%
-44.12
Total Unusual Items
0.33
-67.39%
1.02
-48.95%
1.99
+86.18%
1.07
Total Unusual Items Excluding Goodwill
0.33
-67.39%
1.02
-48.95%
1.99
+86.18%
1.07
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Net Income
-31.93
+2.95%
-32.90
+9.23%
-36.24
+17.98%
-44.19
Pretax Income
-31.93
+2.95%
-32.90
+9.23%
-36.24
+17.98%
-44.19
Net Non Operating Interest Income Expense
4.24
+56.09%
2.72
+71.55%
1.58
+301.27%
0.40
Interest Expense Non Operating
0.01
-67.86%
0.03
-49.09%
0.06
-9.84%
0.06
Net Interest Income
4.24
+56.09%
2.72
+71.55%
1.58
+301.27%
0.40
Interest Expense
0.01
-67.86%
0.03
-49.09%
0.06
-9.84%
0.06
Interest Income Non Operating
4.25
+54.82%
2.75
+67.50%
1.64
+259.65%
0.46
Interest Income
4.25
+54.82%
2.75
+67.50%
1.64
+259.65%
0.46
Other Income Expense
0.33
-67.39%
1.02
-48.95%
1.99
+86.18%
1.07
Other Non Operating Income Expenses
—
—
—
—
Gain On Sale Of Security
0.33
-67.39%
1.02
-48.95%
1.99
+86.18%
1.07
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-31.93
+2.95%
-32.90
+9.23%
-36.24
+17.98%
-44.19
Net Income From Continuing Operation Net Minority Interest
-31.93
+2.95%
-32.90
+9.23%
-36.24
+17.98%
-44.19
Net Income From Continuing And Discontinued Operation
-31.93
+2.95%
-32.90
+9.23%
-36.24
+17.98%
-44.19
Net Income Continuous Operations
-31.93
+2.95%
-32.90
+9.23%
-36.24
+17.98%
-44.19
Normalized Income
-32.26
+4.88%
-33.92
+11.30%
-38.24
+15.51%
-45.26
Net Income Common Stockholders
-31.93
+2.95%
-32.90
+9.23%
-36.24
+17.98%
-44.19
Diluted EPS
—
-0.99
+14.66%
-1.16
+18.88%
-1.43
Basic EPS
—
-0.99
+14.66%
-1.16
+18.88%
-1.43
Basic Average Shares
—
33.16
+6.27%
31.20
+0.83%
30.94
Diluted Average Shares
—
33.16
+6.27%
31.20
+0.83%
30.94
Diluted NI Availto Com Stockholders
-31.93
+2.95%
-32.90
+9.23%
-36.24
+17.98%
-44.19
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
101.93
+40.45%
72.58
-23.96%
95.44
-17.96%
116.33
Current Assets
40.77
-14.35%
47.60
-22.40%
61.34
-31.93%
90.12
Cash Cash Equivalents And Short Term Investments
39.20
-15.22%
46.24
-5.79%
49.08
-40.66%
82.70
Cash And Cash Equivalents
3.94
-2.45%
4.04
+4.20%
3.88
-87.01%
29.88
Cash Equivalents
2.13
+3.30%
2.06
+61.95%
1.27
-95.61%
28.96
Cash Financial
1.82
-8.42%
1.98
-23.96%
2.61
+185.65%
0.91
Other Short Term Investments
35.26
-16.44%
42.19
-6.65%
45.20
-14.44%
52.83
Receivables
0.01
-64.71%
0.03
-99.70%
11.47
+87.63%
6.11
Accounts Receivable
0.01
-64.71%
0.03
-78.75%
0.16
+41.59%
0.11
Other Receivables
—
0.02
-99.83%
11.31
+88.50%
6.00
Prepaid Assets
—
—
—
—
Other Current Assets
1.56
+17.07%
1.33
+67.30%
0.80
-39.22%
1.31
Total Non Current Assets
61.16
+144.90%
24.98
-26.75%
34.10
+30.12%
26.20
Net PPE
1.15
-7.26%
1.24
-38.02%
2.00
-34.65%
3.06
Gross PPE
9.67
+7.48%
8.99
-0.29%
9.02
-3.16%
9.31
Accumulated Depreciation
-8.52
-9.84%
-7.76
-10.45%
-7.02
-12.24%
-6.26
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
3.16
+23.52%
2.56
+1.79%
2.52
-6.54%
2.69
Other Properties
5.73
+1.25%
5.66
-1.24%
5.73
-3.04%
5.91
Leases
0.77
+0.00%
0.77
+0.00%
0.77
+8.73%
0.71
Goodwill And Other Intangible Assets
0.91
-11.31%
1.03
0.00
—
Other Intangible Assets
0.91
-11.31%
1.03
—
—
Investments And Advances
56.58
+157.49%
21.97
-28.75%
30.84
+44.60%
21.33
Other Non Current Assets
2.52
+242.61%
0.74
-41.37%
1.26
-30.78%
1.82
Total Liabilities Net Minority Interest
26.52
+7.08%
24.77
-2.02%
25.28
+45.42%
17.39
Current Liabilities
24.19
-2.35%
24.77
+1.34%
24.44
+57.31%
15.54
Payables And Accrued Expenses
0.86
-56.22%
1.97
+75.80%
1.12
-56.01%
2.55
Payables
0.86
-56.22%
1.97
+88.24%
1.05
-32.43%
1.55
Accounts Payable
0.86
-56.22%
1.97
+88.24%
1.05
-32.43%
1.55
Current Accrued Expenses
—
0.00
-100.00%
0.07
-92.59%
1.00
Pensionand Other Post Retirement Benefit Plans Current
2.56
+77.56%
1.44
+26.22%
1.14
-50.04%
2.29
Current Debt And Capital Lease Obligation
0.00
-99.76%
0.84
-17.68%
1.02
+3.56%
0.98
Current Capital Lease Obligation
0.00
-99.76%
0.84
-17.68%
1.02
+3.56%
0.98
Current Deferred Liabilities
20.32
+0.45%
20.22
-0.06%
20.23
+122.80%
9.08
Current Deferred Revenue
20.32
+0.45%
20.22
-0.06%
20.23
+122.80%
9.08
Other Current Liabilities
0.45
+50.34%
0.30
-68.03%
0.93
+45.37%
0.64
Total Non Current Liabilities Net Minority Interest
2.34
+116750.00%
0.00
-99.76%
0.84
-54.55%
1.85
Long Term Debt And Capital Lease Obligation
2.34
+116750.00%
0.00
-99.76%
0.84
-54.55%
1.85
Long Term Capital Lease Obligation
2.34
+116750.00%
0.00
-99.76%
0.84
-54.55%
1.85
Non Current Deferred Liabilities
—
—
—
—
Preferred Securities Outside Stock Equity
—
—
—
—
Stockholders Equity
75.41
+57.75%
47.80
-31.86%
70.16
-29.09%
98.94
Common Stock Equity
75.41
+57.75%
47.80
-31.86%
70.16
-29.09%
98.94
Capital Stock
0.00
+33.33%
0.00
+0.00%
0.00
+0.00%
0.00
Common Stock
0.00
+33.33%
0.00
+0.00%
0.00
+0.00%
0.00
Share Issued
38.94
+13.96%
34.17
+7.79%
31.70
+2.21%
31.02
Ordinary Shares Number
38.94
+13.96%
34.17
+7.79%
31.70
+2.21%
31.02
Additional Paid In Capital
386.86
+18.11%
327.53
+3.30%
317.07
+2.09%
310.57
Retained Earnings
-311.72
-11.41%
-279.79
-13.32%
-246.90
-17.20%
-210.65
Gains Losses Not Affecting Retained Earnings
0.26
+336.67%
0.06
+500.00%
-0.01
+98.47%
-0.98
Other Equity Adjustments
0.26
+336.67%
0.06
+500.00%
-0.01
+98.47%
-0.98
Total Equity Gross Minority Interest
75.41
+57.75%
47.80
-31.86%
70.16
-29.09%
98.94
Total Capitalization
75.41
+57.75%
47.80
-31.86%
70.16
-29.09%
98.94
Working Capital
16.58
-27.37%
22.83
-38.13%
36.90
-50.53%
74.59
Invested Capital
75.41
+57.75%
47.80
-31.86%
70.16
-29.09%
98.94
Total Debt
2.34
+178.45%
0.84
-54.79%
1.86
-34.37%
2.83
Capital Lease Obligations
2.34
+178.45%
0.84
-54.79%
1.86
-34.37%
2.83
Net Tangible Assets
74.50
+59.26%
46.78
-33.33%
70.16
-29.09%
98.94
Tangible Book Value
74.50
+59.26%
46.78
-33.33%
70.16
-29.09%
98.94
Available For Sale Securities
56.58
+157.49%
21.97
-28.75%
30.84
+44.60%
21.33
Derivative Product Liabilities
—
—
—
—
Interest Payable
—
—
—
—
Investmentin Financial Assets
56.58
+157.49%
21.97
-28.75%
30.84
+44.60%
21.33
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-25.62
-80.58%
-14.19
+47.81%
-27.19
+21.44%
-34.61
Cash Flow From Continuing Operating Activities
-25.62
-80.58%
-14.19
+47.81%
-27.19
+21.44%
-34.61
Net Income From Continuing Operations
-31.93
+2.95%
-32.90
+9.23%
-36.24
+17.98%
-44.19
Depreciation Amortization Depletion
0.94
+12.85%
0.83
-7.44%
0.90
+19.05%
0.76
Depreciation And Amortization
0.94
+12.85%
0.83
-7.44%
0.90
+19.05%
0.76
Other Non Cash Items
0.49
-2.21%
0.50
-8.46%
0.54
+20.35%
0.45
Stock Based Compensation
5.11
-27.14%
7.01
+33.00%
5.27
+4.31%
5.05
Operating Gains Losses
0.31
+134.51%
-0.91
+23.01%
-1.18
-394.56%
-0.24
Gain Loss On Investment Securities
0.31
+134.51%
-0.91
+23.01%
-1.18
-394.56%
-0.24
Change In Working Capital
-0.55
-104.84%
11.28
+220.40%
3.52
-0.93%
3.55
Change In Receivables
0.04
-99.64%
11.42
+313.12%
-5.36
-80.37%
-2.97
Changes In Account Receivables
0.02
-82.54%
0.13
+368.09%
-0.05
+45.35%
-0.09
Change In Prepaid Assets
-0.35
-3420.00%
-0.01
-102.15%
0.47
-35.24%
0.72
Change In Payables And Accrued Expense
-0.33
-172.50%
-0.12
+95.63%
-2.74
-1593.21%
-0.16
Change In Accrued Expense
0.68
+218.61%
-0.57
+75.01%
-2.30
-347.67%
-0.51
Change In Payable
-1.01
-321.76%
0.46
+202.94%
-0.44
-225.57%
0.35
Change In Account Payable
-1.01
-321.76%
0.46
+202.94%
-0.44
-225.57%
0.35
Change In Other Working Capital
0.09
+866.67%
-0.01
-100.11%
11.15
+86.96%
5.97
Investing Cash Flow
-28.50
-342.71%
11.74
+2581.05%
0.44
-92.11%
5.55
Cash Flow From Continuing Investing Activities
-28.50
-342.71%
11.74
+2581.05%
0.44
-92.11%
5.55
Net PPE Purchase And Sale
-0.73
-1196.43%
-0.06
-130.60%
0.18
+123.61%
-0.78
Purchase Of PPE
-0.73
-1196.43%
-0.06
+56.25%
-0.13
+83.82%
-0.79
Sale Of PPE
—
0.00
-100.00%
0.31
+1843.75%
0.02
Capital Expenditure
-0.73
+34.06%
-1.10
-760.16%
-0.13
+83.82%
-0.79
Net Investment Purchase And Sale
-27.78
-316.26%
12.84
+4936.86%
0.26
-95.97%
6.33
Purchase Of Investment
-87.61
-144.51%
-35.83
+33.82%
-54.14
-12.63%
-48.07
Sale Of Investment
59.84
+22.93%
48.67
-10.52%
54.40
0.00%
54.40
Net Intangibles Purchase And Sale
0.00
+100.00%
-1.04
0.00
—
Purchase Of Intangibles
0.00
+100.00%
-1.04
0.00
—
Financing Cash Flow
54.03
+1970.76%
2.61
+246.94%
0.75
+14940.00%
0.01
Cash Flow From Continuing Financing Activities
54.03
+1970.76%
2.61
+246.94%
0.75
+14940.00%
0.01
Net Issuance Payments Of Debt
-0.19
+55.91%
-0.44
+5.58%
-0.47
-53.80%
-0.30
Issuance Of Debt
—
—
—
—
Repayment Of Debt
-0.19
+55.91%
-0.44
+5.58%
-0.47
-53.80%
-0.30
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
-0.19
+55.91%
-0.44
+5.58%
-0.47
-53.80%
-0.30
Net Long Term Debt Issuance
-0.19
+55.91%
-0.44
+5.58%
-0.47
-53.80%
-0.30
Net Common Stock Issuance
53.61
0.00
—
0.00
Proceeds From Stock Option Exercised
0.61
-79.99%
3.05
+150.33%
1.22
+295.45%
0.31
Changes In Cash
-0.10
-160.74%
0.16
+100.63%
-26.00
+10.52%
-29.05
Beginning Cash Position
4.04
+4.20%
3.88
-87.01%
29.88
-49.30%
58.93
End Cash Position
3.94
-2.45%
4.04
+4.20%
3.88
-87.01%
29.88
Free Cash Flow
-26.35
-72.33%
-15.29
+44.03%
-27.32
+22.84%
-35.40
Interest Paid Supplemental Data
0.01
-67.86%
0.03
-49.09%
0.06
+14.58%
0.05
Common Stock Issuance
53.61
0.00
—
0.00
Issuance Of Capital Stock
53.61
0.00
—
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category